ARCH Venture Partners VII, L.P.

10% owner at Neumora Therapeutics, Inc. · on record since Sep 20, 2023
10% owner at BLUE MARTINI SOFTWARE INC · on record since Jun 26, 2013
10% owner at Receptos, Inc. · on record since May 14, 2013
10% owner at AGIOS PHARMACEUTICALS, INC. · on record since Jul 31, 2013
10% owner at SAGE FUND LP · on record since Jul 23, 2014
10% owner at JUNO LIGHTING INC · on record since Dec 23, 2014
10% owner at Pulmatrix, Inc. · on record since Jun 25, 2015
10% owner at Syros Pharmaceuticals, Inc. · on record since Jun 29, 2016
10% owner at PHASERX, INC. · on record since May 25, 2016
10% owner at Unity Biotechnology, Inc. · on record since May 7, 2018
Former 10% owner at Pulmatrix, Inc. · on record since Apr 5, 2018
10% owner at Twist Bioscience Corp · on record since Oct 30, 2018
10% owner at Greenwave Technology Solutions, Inc. · on record since Dec 22, 2020

Insider trading activity of ARCH Venture Partners VII, L.P.

Figures computed from official regulatory filings — .

Insufficient history for a statistical track record (fewer than 5 open-market buys).

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Syros Pharmaceuticals, Inc.Listing on record	Jul 17, 2019	Sell	-25,779	7.81 USD	$201.3K	Unusual size	SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 17, 2019	Sell	-34,521	7.70 USD	$265.8K	Unusual size	SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 17, 2019	Sell	-2,700	8.27 USD	$22.3K		SEC
Pulmatrix, Inc.Listing on record	Apr 5, 2018	BuyD (derivative)	1,150,000	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
Pulmatrix, Inc.Listing on record	Apr 5, 2018	BuyD (derivative)	1,150,000	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
Pulmatrix, Inc.Listing on record	Apr 5, 2018	Buy	1,150,000	—	n/a (No price was disclosed in the filing)	conv 71ClusterFirst in 12mo	SEC
PHASERX, INC.Listing on record	May 25, 2016	AwardD (derivative)	9,385	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PHASERX, INC.Listing on record	May 25, 2016	Buy	1,000,000	5.00 USD	$5M	conv 70ClusterFirst in 12mo	SEC
PHASERX, INC.Listing on record	May 25, 2016	Sell	-195,156	0.01 USD	$2K		SEC
PHASERX, INC.Listing on record	May 25, 2016	Sell	-484,903	0.01 USD	$4.8K		SEC
AGIOS PHARMACEUTICALS, INC.Listing on record	Jun 25, 2014	Other	-386,074	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Syros Pharmaceuticals, Inc.Listing on record	Jul 17, 2019	Sell	-25,779	7.81 USD	$201.3K	Unusual size	SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 17, 2019	Sell	-34,521	7.70 USD	$265.8K	Unusual size	SEC
Syros Pharmaceuticals, Inc.Listing on record	Jul 17, 2019	Sell	-2,700	8.27 USD	$22.3K		SEC
Pulmatrix, Inc.Listing on record	Apr 5, 2018	BuyD (derivative)	1,150,000	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
Pulmatrix, Inc.Listing on record	Apr 5, 2018	BuyD (derivative)	1,150,000	—	n/a (No price was disclosed in the filing)	ClusterFirst in 12mo	SEC
Pulmatrix, Inc.Listing on record	Apr 5, 2018	Buy	1,150,000	—	n/a (No price was disclosed in the filing)	conv 71ClusterFirst in 12mo	SEC
PHASERX, INC.Listing on record	May 25, 2016	AwardD (derivative)	9,385	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
PHASERX, INC.Listing on record	May 25, 2016	Buy	1,000,000	5.00 USD	$5M	conv 70ClusterFirst in 12mo	SEC
PHASERX, INC.Listing on record	May 25, 2016	Sell	-195,156	0.01 USD	$2K		SEC
PHASERX, INC.Listing on record	May 25, 2016	Sell	-484,903	0.01 USD	$4.8K		SEC
AGIOS PHARMACEUTICALS, INC.Listing on record	Jun 25, 2014	Other	-386,074	—	n/a (No price was disclosed in the filing)		SEC